First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Salamero, Olga
  • Willekens, Christophe
  • Pérez-Simón J.A.
  • Pigneux, Arnaud
  • Recher, Christian
  • Popat, Rakesh
  • Carpio, Cecilia
  • Molinero, Cesar
  • Mascaro, Cristina
  • Vila, Joaquim
  • Arévalo MI
  • Maes, Tamara
  • Buesa, Carlos
  • Bosch, Francesc
  • Somervaille T.C.P.

Grupos

Abstract

Iadademstat is a novel, highly potent, and selective inhibitor of LSD1 (KDM1A), with preclinical in vitro and in vivo antileukemic activity. This study aimed to determine safety and tolerability of iadademstat as monotherapy in patients with relapsed/refractory acute myeloid leukemia (R/R AML).

Datos de la publicación

ISSN/ISSNe:
0732-183X, 1527-7755

JOURNAL OF CLINICAL ONCOLOGY  LIPPINCOTT WILLIAMS & WILKINS

Tipo:
Article
Páginas:
4260-4273
PubMed:
33052756
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
10,482 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 94

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Adult; Aged; Aged, 80 and over; Enzyme Inhibitors; Female; Histone Demethylases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; antibiotic agent; dexamethasone; histone demethylase; hydroxyurea; iadademstat; lysine; prednisolone; steroid; thymocyte antibody; enzyme inhibitor; histone demethylase; abdominal pain; acute graft versus host disease; acute myeloid leukemia; adult; aged; anemia; anorexia; antileukemic activity; area under the curve; Article; asthenia; blast cell; bone marrow suppression; brain hemorrhage; cancer chemotherapy; cancer recurrence; cell differentiation; clinical article; cohort analysis; controlled study; convalescence; diarrhea; dose response; drug blood level; drug dose escalation; drug dose reduction; drug efficacy; drug half life; drug megadose; drug safety; drug tolerability; edema; faintness; febrile neutropenia; female; graft versus host reaction; heart failure; human; hyperglycemia; hypokalemia; hypotension; infection; leukocytosis; leuk

Campos de Estudio

Compartir